Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

RASGRP2 antibody (C-Term)

The Rabbit Polyclonal anti-RASGRP2 antibody (ABIN5564284) specifically detects RASGRP2 in WB. The antibody is reactive with Human and Mouse samples.
Catalog No. ABIN5564284
-20% for 20 Years of ABO
$500.26
$625.32
save $125.06 (-20 %)
Plus shipping costs $50.00
100 μL
Shipping to: United States
Delivery in 5 to 10 Business Days

Quick Overview for RASGRP2 antibody (C-Term) (ABIN5564284)

Target

See all RASGRP2 Antibodies
RASGRP2 (RAS Guanyl Releasing Protein 2 (Calcium and DAG-Regulated) (RASGRP2))

Reactivity

  • 31
  • 5
  • 4
  • 2
  • 2
  • 1
  • 1
Human, Mouse

Host

  • 28
  • 3
Rabbit

Clonality

  • 29
  • 2
Polyclonal

Conjugate

  • 21
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This RASGRP2 antibody is un-conjugated

Application

  • 29
  • 14
  • 10
  • 8
  • 4
  • 3
  • 1
  • 1
Western Blotting (WB)
  • Binding Specificity

    • 12
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    C-Term

    Purpose

    anti-RasGRP2, pAb (IG-09)

    Specificity

    Recognizes human and mouse RasGRP2.

    Characteristics

    Polyclonal Antibody. Recognizes human and mouse RasGRP2. Source: Rabbit. Applications: WB. Liquid. In PBS containing 2 mg/mL BSA and 0.05 % sodium azide. RasGRP2 functions as a calcium- and DAG-regulated nucleotide exchange factor specifically activating small GTPases, including Rap1/RAS3, through the exchange of bound GDP for GTP. It may also activate other GTPases such as RRAS, RRAS2, NRAS, KRAS but not HRAS. The protein is expressed in platelets, neutrophils and T lymphocytes. RasGRP2 functions in aggregation of platelets and adhesion of T lymphocytes and neutrophils probably through inside-out integrin activation. S587 was identified as the major PKA phosphorylation. Phosphorylation of S587 correlated with the inhibitory effect of PKA on Rap1b activation in platelets. In vitro, ERK1/2 phosphorylates RasGRP2 at Ser394 to limit its exchange activity and inhibits its ability to activate the small GTPase Rap1 that ultimately leads to decreased activation of ERK1/2 in cells.

    Purification

    Antigen affinity purified.

    Purity

    Antigen affinity purified.

    Immunogen

    Synthetic peptide corresponding to a human RasGRP2 sequence located at the C-terminus of the RasGEF domain.
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    In PBS containing 2 mg/mL BSA and 0.05 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Do not freeze.Keep sterile.

    Storage

    4 °C

    Storage Comment

    +4°C

    +4°C

    Stable for at least 6 months after receipt when stored at +4°C.

    Expiry Date

    6 months
  • Target

    RASGRP2 (RAS Guanyl Releasing Protein 2 (Calcium and DAG-Regulated) (RASGRP2))

    Alternative Name

    RasGRP2

    Background

    Alternate Names/Synonyms: CalDAG-GEFI, Ras Guanyl Nucleotide-releasing Protein 2, Ras Guanyl Releasing Protein 2, CDC25-like Protein, CDC25L, Calcium and DAG-regulated Guanine Nucleotide Exchange Factor I, MCG7

    Product Description: RasGRP2 functions as a calcium- and DAG-regulated nucleotide exchange factor specifically activating small GTPases, including Rap1/RAS3, through the exchange of bound GDP for GTP. It may also activate other GTPases such as RRAS, RRAS2, NRAS, KRAS but not HRAS. The protein is expressed in platelets, neutrophils and T lymphocytes. RasGRP2 functions in aggregation of platelets and adhesion of T lymphocytes and neutrophils probably through inside-out integrin activation. S587 was identified as the major PKA phosphorylation. Phosphorylation of S587 correlated with the inhibitory effect of PKA on Rap1b activation in platelets. In vitro, ERK1/2 phosphorylates RasGRP2 at Ser394 to limit its exchange activity and inhibits its ability to activate the small GTPase Rap1 that ultimately leads to decreased activation of ERK1/2 in cells.

    UniProt

    Q7LDG7

    Pathways

    TCR Signaling
You are here:
Chat with us!